https://www.wiredprnews.com/brii-biosciences-exercises-option-for-vir-biotechnologys-vir-3434-a-broadly-neutralizing-monoclonal-antibody-targeting-hepatitis-b-in-greater-china-press-release/
Brii Biosciences Exercises Option for Vir Biotechnology’s VIR-3434, a Broadly Neutralizing Monoclonal Antibody Targeting Hepatitis B in Greater China – Press Release